Search Results - "Jamerson, B."

Refine Results
  1. 1

    Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial by Tashkin, DP, Kanner, R, Bailey, W, Buist, S, Anderson, P, Nides, MA, Gonzales, D, Dozier, G, Patel, MK, Jamerson, BD

    Published in The Lancet (British edition) (19-05-2001)
    “…Tobacco smoking is associated with chronic obstructive pulmonary disease (COPD) in more than 80% of cases. Our aim was to investigate the effect of…”
    Get full text
    Journal Article
  2. 2

    Prevalence of sexual dysfunction among newer antidepressants by CLAYTON, Anita H, PRADKO, James F, CROFT, Harry A, MONTANO, C. Brendan, LEADBETTER, Robert A, BOLDEN-WATSON, Carolyn, BASS, Kristin I, DONAHUE, Rafe M. J, JAMERSON, Brenda D, METZ, Alan

    Published in The journal of clinical psychiatry (01-04-2002)
    “…Sexual dysfunction commonly occurs during antidepressant treatment. However, the reported rates of sexual dysfunction vary across antidepressants and are…”
    Get full text
    Journal Article
  3. 3

    Initial Clinical Experience with Remifentanil, a New Opioid Metabolized by Esterases by Dershwitz, Mark, Randel, Gail I., Rosow, Carl E., Fragen, Robert J., Connors, Patricia M., Librojo, Eleanor S., Shaw, Dea L., Peng, Amy W., Jamerson, Brenda D.

    Published in Anesthesia and analgesia (01-09-1995)
    “…Remifentanil is a new, esterase-metabolized opioid for anesthesia. Nonspecific esterases terminate the drug effect, with a context-sensitive half-time which…”
    Get full text
    Journal Article
  4. 4

    Late-term smoking cessation despite initial failure: an evaluation of bupropion sustained release, nicotine patch, combination therapy, and placebo by Jamerson, Brenda D., Nides, Mitchell, Jorenby, Douglas E., Donahue, Rafe, Garrett, Peter, Andrew Johnston, J., Fiore, Michael C., Rennard, Stephen I., Leischow, Scott J.

    Published in Clinical therapeutics (01-05-2001)
    “…Objective: The purpose of this study was to evaluate the efficacy of long-term use of bupropion sustained release (SR), the nicotine patch, and the combination…”
    Get full text
    Journal Article
  5. 5

    A comparison of remifentanil and fentanyl in patients undergoing surgery for intracranial mass lesions by BALAKRISHNAN, G, RAUDZENS, P, SAMRA, S. K, SONG, K, BOENING, J. A, BOSEK, V, JAMERSON, B. D, WARNER, D. S

    Published in Anesthesia and analgesia (01-07-2000)
    “…We compared the effects of remifentanil versus fentanyl during surgery for intracranial space-occupying lesions. Patients were randomly assigned to receive…”
    Get full text
    Journal Article
  6. 6

    Intracranial Pressure and Hemodynamic Effects of Remifentanil Versus Alfentanil in Patients Undergoing Supratentorial Craniotomy by Warner, David S., Hindman, Bradley J., Todd, Michael M., Sawin, Paul D., Kirchner, Jerry, Roland, Carl L., Jamerson, Brenda D.

    Published in Anesthesia and analgesia (01-08-1996)
    “…Remifentanil hydrochloride is an ultra-short-acting esterase metabolized mu-opioid receptor agonist. The purpose of this study was to provide preliminary…”
    Get full text
    Journal Article
  7. 7

    Bupropion SR as an aid to smoking cessation in smokers treated previously with bupropion: A randomized placebo-controlled study by Gonzales, David H., Nides, Mitchell A., Ferry, Linda H., Kustra, Robert P., Jamerson, Brenda D., Segall, Nathan, Herrero, Luis A., Krishen, Alok, Sweeney, Addison, Buaron, Kathleen, Metz, Alan

    Published in Clinical pharmacology and therapeutics (01-06-2001)
    “…Background Many persons who attempt to quit smoking have made previous unsuccessful attempts to quit with pharmacologic aids. An understanding of the impact of…”
    Get full text
    Journal Article
  8. 8

    Remifentanil versus remifentanil/midazolam for ambulatory surgery during monitored anesthesia care by GOLD, M. I, WATKINS, W. D, SUNG, Y.-F, YARMUSH, J, CHUNG, F, UY, N. T, MAURER, N. W, CLARKE, M. Y, JAMERSON, B. D

    Published in Anesthesiology (Philadelphia) (01-07-1997)
    “…This study was designed to define the appropriate dose of remifentanil hydrochloride alone or combined with midazolam to provide satisfactory comfort and…”
    Get full text
    Journal Article
  9. 9

    Assessing a tool to measure patient functional ability after outpatient surgery by HOGUE, S. L, REESE, P. R, COLOPY, M, FLEISHER, L. A, TUMAN, K. J, TWERSKY, R. S, WARNER, D. S, JAMERSON, B

    Published in Anesthesia and analgesia (01-07-2000)
    “…The "24-Hour Functional Ability Questionnaire" (24hFAQ) was developed to measure final recovery and satisfaction 24 h after surgery. We used structured…”
    Get full text
    Journal Article
  10. 10

    Oral sumatriptan for the long-term treatment of migraine: clinical findings by Rederich, G, Rapoport, A, Cutler, N, Hazelrigg, R, Jamerson, B

    Published in Neurology (01-08-1995)
    “…This double-blind, placebo-controlled, crossover study of the acute treatment of migraine investigated the efficacy and tolerability of oral sumatriptan 100 mg…”
    Get full text
    Journal Article
  11. 11

    Remifentanil Compared with Alfentanil for Ambulatory Surgery Using Total Intravenous Anesthesia by Philip, Beverly K., Scuderi, Philip E., Chung, Frances, Conahan, Thomas J., Maurer, Walter, Angel, John J., Kallar, Surinder K., Skinner, Elizabeth P., Jamerson, Brenda D.

    Published in Anesthesia and analgesia (01-03-1997)
    “…The purpose of this study was to test the hypothesis that using a 1:4 ratio of remifentanil to alfentanil, a remifentanil infusion would provide better…”
    Get full text
    Journal Article
  12. 12

    Venous irritation related to intravenous administration of phenytoin versus fosphenytoin by Jamerson, B D, Dukes, G E, Brouwer, K L, Donn, K H, Messenheimer, J A, Powell, J R

    Published in Pharmacotherapy (01-01-1994)
    “…To compare the frequency, severity, and time course of venous irritation after administration of a single intravenous dose of phenytoin with an equimolar dose…”
    Get more information
    Journal Article
  13. 13

    Effect of Nonnicotine Pharmacotherapy on Smoking Behavior by Kotlyar, Michael, Golding, Michael, Hatsukami, Dorothy K., Jamerson, Brenda D.

    Published in Pharmacotherapy (01-12-2001)
    “…Smoking‐related disease is the single biggest preventable cause of morbidity and mortality in the United States, yet approximately 25% of Americans continue to…”
    Get full text
    Journal Article
  14. 14

    Is there a learning curve associated with the use of remifentanil? by JOSHI, Girish P, JAMERSON, Brenda D, ROIZEN, Michael F, FLEISHER, Lee, TWERSKY, Rebecca S, WARNER, David S, COLOPY, Michael

    Published in Anesthesia and analgesia (01-11-2000)
    “…This study prospectively determined whether there was a learning curve with the use of remifentanil, as indicated by decreased hemodynamic variability,…”
    Get full text
    Journal Article
  15. 15

    Does Functional Ability in the postoperative period differ between remifentanil- and fentanyl-based anesthesia? by FLEISHER, Lee A, HOGUE, Susan, COLOPY, Mike, TWERSKY, Rebecca S, WARNER, David S, JAMERSON, Brenda D, TUMAN, Kenneth J, GLASS, Peter S. A, ROIZEN, Michael F

    Published in Journal of clinical anesthesia (01-09-2001)
    “…To compare patients' functional ability in the 24-hour postoperative period following a remifentanil compared to a hypnotic-fentanyl-treated anesthesia regimen…”
    Get full text
    Journal Article
  16. 16

    Turbo coding for the noisy 2-user binary adder channel with punctured convolutional codes by Alcoforado, Maria de Lourdes M. G., de Jesus, Jamerson J. C. B., da Rocha, Valdemar C.

    Published in Telecommunication systems (01-03-2017)
    “…This paper investigates the use of punctured recursive systematic convolutional codes for turbo coding in a 2-user binary adder channel (2-BAC) in the presence…”
    Get full text
    Journal Article
  17. 17

    A placebo-controlled comparison of the effects on sexual functioning of bupropion sustained release and fluoxetine by Coleman, Charles C., King, Benjamin R., Bolden-Watson, Carolyn, Book, Martin J., Taylor Segraves, R., Richard, Nathalie, Ascher, John, Batey, Sharyn, Jamerson, Brenda, Metz, Alan

    Published in Clinical therapeutics (01-07-2001)
    “…Background: Many antidepressants are associated with sexual dysfunction, a side effect that may lead to patients' dissatisfaction and noncompliance with…”
    Get full text
    Journal Article
  18. 18

    A Multicenter Evaluation of Total Intravenous Anesthesia with Remifentanil and Propofol for Elective Inpatient Surgery by Hogue, Charles W., Bowdle, T. Andrew, OʼLeary, Colleen, Duncalf, Deryck, Miguel, Rafael, Pitts, Melvin, Streisand, James, Kirvassilis, George, Jamerson, Brenda, McNeal, Sally, Batenhorst, Randal

    Published in Anesthesia and analgesia (01-08-1996)
    “…Remifentanil is a mu-opioid receptor agonist with a context sensitive half-time of 3 min and an elimination half-life <or=to10 min. This study sought to…”
    Get full text
    Journal Article
  19. 19

    Targeting smokers at increased risk for relapse: treating women and those with a history of depression by Smith, Stevens S., Jorenby, Douglas E., Leischow, Scott J., Nides, Mitchell A., Rennard, Stephen I., Johnston, J. Andrew, Jamerson, Brenda, Fiore, Michael C., Baker, Timothy B.

    Published in Nicotine & tobacco research (01-02-2003)
    “…Some studies have shown that female smokers and smokers with a history of depression have an increased risk of relapse following smoking cessation treatment…”
    Get full text
    Journal Article
  20. 20

    Absolute bioavailability of phenytoin after 3-phosphoryloxymethyl phenytoin disodium (ACC-9653) administration to humans by Jamerson, B D, Donn, K H, Dukes, G E, Messenheimer, J A, Brouwer, K L, Powell, J R

    Published in Epilepsia (Copenhagen) (01-09-1990)
    “…3-Phosphoryloxymethyl phenytoin disodium (ACC-9653) is a water-soluble investigational phenytoin (PHT) prodrug for parenteral administration. The objectives of…”
    Get more information
    Journal Article